Brief: Point Biopharma Reports Fourth Quarter And Full Year 2022 Financial Results

POINT Biopharma Global

27/03/2023 13:27

March 27 (Reuters) - Point Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
    * POINT BIOPHARMA GLOBAL-CASH, CASH EQUIVALENTS &
INVESTMENTS WERE
$541.3 MILLION AS OF DEC 31, 2022, WHICH IS ANTICIPATED TO FUND
OPERATIONS INTO FISCAL 2026
    * POINT BIOPHARMA GLOBAL- NET INCOME WAS $163.3 MILLION, OR
$1.55
& $1.53 NET INCOME PER BASIC & DILUTED SHARE, RESPECTIVELY, FOR
QUARTER ENDED DEC 31, 2022
    * ANTICIPATE DATA FROM FULL FRONTIER STUDY TO BE AVAILABLE
IN
FIRST HALF OF 2024
    * Q4 EARNINGS PER SHARE VIEW $-0.26 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9vhhtB 
Further company coverage:  PNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))